Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO ...

After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...

Just Because I am a Librarian doesn’t mean I have to dress like one.” With this breezy pronouncement, Belle da Costa Greene handily differentiated herself from most librarians. She stood out for other ...